Previous 10 | Next 10 |
Global Cord Blood had a decent quarter, with subscriber growth improving both YoY and QoQ. This company is very cheap with 146% net cash to market cap. 24% EPS CAGR over the last 5-year period. Changes in birthing policy in China - will bode well for the company. A market ...
Image source: The Motley Fool. Global Cord Blood Corporation (NYSE: CO) Q4 2021 Earnings Call Jun 29, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Global Cord Blood Corporation (CO) Q4 2021 Earnings Call Transcri...
Global Cord Blood Corporation (CO) Q4 2021 Earnings Conference Call June 29, 2021 8:00 am ET Corporate Participants Cathy Bai - VP of Corporate Finance Albert Chen - Chief Financial Officer Conference Call Participants Sandy Mehta - Evaluate Research Cyrille Pichot - Altimeo Presentation Oper...
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results Earnings Call Scheduled for 8:00 a.m. ET on June 29, 2021 PR Newswire HONG KONG , June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "C...
Shares of Global Cord Blood Corporation (NYSE:CO) traded at a new 52-week high today of $5.17. So far today approximately 100,000 shares have been exchanged, as compared to an average 30-day volume of 221,000 shares. Based on a current price of $5.13, Global Cord Blood Corporation is cur...
Shares of Global Cord Blood Corporation (NYSE:CO) traded today at $4.99, eclipsing its 52-week high. This new high was reached on above average trading volume as 290,000 shares traded hands, while the average 30-day volume is approximately 208,000 shares. Global Cord Blood Corp provides ...
Shares of Global Cord Blood Corporation (NYSE: CO) , a provider of umbilical cord blood stem cells storage, are rising sharply on Tuesday, following the company's announcement of an unsolicited non-binding acquisition proposal. As of 12:25 p.m. EST, Global Cord Blood's stock was up ...
Alternate Ocean Investment, a wholly-owned subsidiary of Haitong International Securities (HTNGF) has made an offer to Global Cord Blood (CO) to acquire all of the outstanding ordinary shares for $5/share in cash. The Board will carefully review the unsolicited proposal to determine the ...
NanoViricides (NNVC) +112% on effectiveness of COVID-19 drug candidates in cell culture studies.Communications Systems (JCS) +38% after entering merger agreement with Pineapple Energy.STRATA Skin Sciences (SSKN) +30% on announcing CEO Transition.CHF Solutions (CHFS) +25%.AgeX T...
Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposal Shareholders Advised to Take No Action Pending Board Review PR Newswire HONG KONG , March 2, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" ...
News, Short Squeeze, Breakout and More Instantly...
Global Cord Blood Corporation Company Name:
CO Stock Symbol:
NYSE Market:
Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the...
Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today announced the Grand Court of the Cayman Islands (the “Court”...
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM PR Newswire HONG KONG , July 6, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provide...